|
|
Volumn 173, Issue SUPPL. 36, 1998, Pages 12-18
|
|
Building castles on sands or quicksands? The strengths and weaknesses of economic evaluation in pharmaceuticals
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHLORPROMAZINE;
CLOZAPINE;
FLUPHENAZINE;
HALOPERIDOL;
NEUROLEPTIC AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
RISPERIDONE;
THIORIDAZINE;
TRIFLUOPERAZINE;
CLINICAL TRIAL;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DRUG CHOICE;
DRUG COST;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG SAFETY;
HEALTH CARE POLICY;
HUMAN;
PRACTICE GUIDELINE;
RESTLESSNESS;
REVIEW;
SCHIZOPHRENIA;
TARDIVE DYSKINESIA;
TREMOR;
|
|
EID: 0031659952
PISSN: 00071250
EISSN: None
Source Type: Journal
DOI: 10.1192/s0007125000298000 Document Type: Review |
|
Times cited : (14)
|
|
References (52)
|
